Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EOG Resources (EOG) Surpasses Q3 Earnings Estimates
EOG Resources (EOG) Surpasses Q3 Earnings Estimates

EOG Resources (EOG) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.89 per share a year ago. These

VTEX (VTEX) Meets Q3 Earnings Estimates
VTEX (VTEX) Meets Q3 Earnings Estimates

VTEX (VTEX) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures

Camden (CPT) Tops Q3 FFO Estimates
Camden (CPT) Tops Q3 FFO Estimates

Camden (CPT) came out with quarterly funds from operations (FFO) of $1.7 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to FFO of $1.71 per share a year ago. These

Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates
Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates

Dropbox (DBX) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.6 per share a year ago. These figures are

Block (XYZ) Misses Q3 Earnings and Revenue Estimates
Block (XYZ) Misses Q3 Earnings and Revenue Estimates

Block (XYZ) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.88 per share a year ago. These figures are

Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates
Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates

Solventum (SOLV) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.64 per share a year ago. These figures

Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue Estimates
Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue Estimates

Monster Beverage (MNST) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.4 per share a year ago. These

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago. These figures

Celanese (CE) Beats Q3 Earnings Estimates
Celanese (CE) Beats Q3 Earnings Estimates

Celanese (CE) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.44 per share a year ago. These figures are

Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates
Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates

Akamai Technologies (AKAM) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.59 per share a year ago

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $1.34 per share a year ago

Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates
Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates

Progyny (PGNY) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.4 per share a year ago. These figures are

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago. These figures are

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Lags Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Lags Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of $1.38 per share versus the Zacks Consensus Estimate of a loss of $1.27. This compares to a loss of $0.96 per share a year

Airbnb, Inc. (ABNB) Misses Q3 Earnings Estimates
Airbnb, Inc. (ABNB) Misses Q3 Earnings Estimates

Airbnb, Inc. (ABNB) came out with quarterly earnings of $2.21 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $2.13 per share a year ago. These

Gen Digital (GEN) Q2 Earnings and Revenues Top Estimates
Gen Digital (GEN) Q2 Earnings and Revenues Top Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.54 per share a year ago. These figures

Wynn Resorts (WYNN) Misses Q3 Earnings Estimates
Wynn Resorts (WYNN) Misses Q3 Earnings Estimates

Wynn Resorts (WYNN) came out with quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.9 per share a year ago. These

The Trade Desk (TTD) Q3 Earnings and Revenues Top Estimates
The Trade Desk (TTD) Q3 Earnings and Revenues Top Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.41 per share a year ago. These

Expedia (EXPE) Q3 Earnings and Revenues Surpass Estimates
Expedia (EXPE) Q3 Earnings and Revenues Surpass Estimates

Expedia (EXPE) came out with quarterly earnings of $7.57 per share, beating the Zacks Consensus Estimate of $7.21 per share. This compares to earnings of $6.13 per share a year ago. These figures

Blend Labs (BLND) Reports Break-Even Earnings for Q3
Blend Labs (BLND) Reports Break-Even Earnings for Q3

Blend Labs (BLND) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.02. This compares to break-even earnings per share a year ago. These figures are adjusted

GigaCloud Technology Inc. (GCT) Beats Q3 Earnings and Revenue Estimates
GigaCloud Technology Inc. (GCT) Beats Q3 Earnings and Revenue Estimates

GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.98 per share a year ago

Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates
Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates

Curis (CRIS) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to a loss of $1.7 per share a year ago. These figures are

After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms: https://www.marketbeat.com/logos/articles/med_20251105145333_after-16-fall-analysts-eye-a-big-recovery-in-meta.jpg
After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms

Meta Platforms (NASDAQ: META) just saw its biggest post-earnings fall in three years.

Shares dropped by over 11% on Oct. 30 as investors reacted to the company’s Q3 2025 earnings and commentary

Top Stock Reports for Morgan Stanley, Union Pacific & Southern Company
Top Stock Reports for Morgan Stanley, Union Pacific & Southern Company

Thursday, November 6, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Morgan